---
title: "Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295407468.md"
description: "Morgan Stanley analyst Erin Wright reaffirmed a Hold rating on Elanco Animal Health (ELAN) with a $26 price target. While Stifel Nicolaus also issued a Hold, Piper Sandler maintained a Buy rating for the stock."
datetime: "2026-08-10T12:26:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295407468.md)
  - [en](https://longbridge.com/en/news/295407468.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295407468.md)
generator: "portal-rs"
---

# Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)

Morgan Stanley analyst Erin Wright maintained a Hold rating on Elanco Animal Health today and set a price target of $26.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Wright covers the Healthcare sector, focusing on stocks such as CVS Health, UnitedHealth, and Humana. According to TipRanks, Wright has an average return of 15.2% and a 64.19% success rate on recommended stocks. 

In addition to Morgan Stanley, Elanco Animal Health also received a Hold from Stifel Nicolaus’s Jonathan Block in a report issued on July 31. However, today, Piper Sandler maintained a Buy rating on Elanco Animal Health (NYSE: ELAN).

### Related Stocks

- [ELAN.US](https://longbridge.com/en/quote/ELAN.US.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)
- [UNH.US](https://longbridge.com/en/quote/UNH.US.md)
- [HUM.US](https://longbridge.com/en/quote/HUM.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [Barclays Sticks to Its Buy Rating for Elanco Animal Health (ELAN)](https://longbridge.com/en/news/296759200.md)
- [Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility | ELAN Stock News](https://longbridge.com/en/news/297049575.md)
- [Top Executive Quietly Boosts Stake in Elanco Animal Health](https://longbridge.com/en/news/296293784.md)
- [Elanco Animal Health (ELAN) Lifted Guidance, Is The 21% Discount Still There?](https://longbridge.com/en/news/296298826.md)
- [Elanco director Lawrence Kurzius acquires 40,000 common shares for $935,920](https://longbridge.com/en/news/296649591.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**